Abstract:A series of novel 1,4-pentadien-3-one derivatives containing 4-thioquinazoline moiety were designed and synthesized. Antiviral bioassay results indicated that most of the title compounds exhibited excellent antiviral activities against tobacco mosaic virus (TMV) and cucumber mosaic virus (CMV) in vivo. Among the title compounds, 7j exhibited the best curative activity against TMV, with a half-maximal effective concentration (EC50) value of 213.5 μg/mL, which was better than that of ningnanmycin (270.9 μg/mL). Meanwhile, 7a showed remarkable protection activity against TMV and curative activity against CMV, with EC50 values of 124.3 and 365.5 μg/mL, respectively, which were superior to those of ningnanmycin (195.1 and 404.9 μg/mL, respectively). Comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA) models were generated on the basis of the curative activities against TMV and exhibited good predictive abilities with cross-validated q(2) and non-cross-validated r(2) values for CoMFA and CoMSIA of 0.548, 0.647 and 0.994, 0.993, respectively. These results provided a practical tool for guiding the design and synthesis of novel and more potent 1,4-pentadien-3-one derivatives containing 4-thioquinazoline moiety.

Synthesis and antiviral bioactivities of novel chiral bis-thiourea-type derivatives containing α-aminophosphonate moiety

Synthesis And Antiviral Bioactivities Of Novel Chiral Bis-Thiourea-Type Derivatives Containing Alpha-Aminophosphonate Moiety

Synthesis and Antiviral Activities of Chiral Thiourea Derivatives Containing an Alpha-Aminophosphonate Moiety.

Synthesis and Antiviral Bioactivity of Chiral Thioureas Containing Leucine and Phosphonate Moieties

Synthesis and Antiviral Activity of 2-Cyano-3-(4-methylbenzo[d]thiazol-2-amino)-3-phenyl Acrylate Derivatives

Synthesis and Antiviral Bioactivity of Novel Chalcone Derivatives Containing Purine Moiety

Synthesis and Antiviral Bioactivity of Novel 2‐substituted Methlthio‐5‐(4‐Amino‐2‐Methylpyrimidin‐5‐yl)‐1,3,4‐Thiadiazole Derivatives

Synthesis and antiviral activity of novel chiral cyanoacrylate derivatives.

Synthesis And Antiviral Activities Of Cyanoacrylate Derivatives Containing An Alpha-Aminophosphonate Moiety

Synthesis and antiviral activities of novel chiral cyanoacrylate derivatives with (E) configuration.

Synthesis and Antiviral Activity of 2-Substituted Methylthio-5-(4-Amino-2-Methylpyrimidin-5-Yl)-1,3,4-Oxadiazole Derivatives

Synthesis And Antiviral Activities Of Amide Derivatives Containing The Alpha-Aminophosphonate Moiety

Novel Α,β-Unsaturated Amide Derivatives Bearing Α-Amino Phosphonate Moiety As Potential Antiviral Agents

Synthesis and Antiviral Evaluation of Novel 1,3,4-Oxadiazole/thiadiazole-chalcone Conjugates

Synthesis, Anti-Tobacco Mosaic Virus and Cucumber Mosaic Virus Activity, and 3D-QSAR Study of Novel 1,4-Pentadien-3-one Derivatives Containing 4-Thioquinazoline Moiety.

Synthesis and Antiviral Activities of Amide Derivatives Containing the α-Aminophosphonate Moiety

Synthesis, Antiviral Activity, and 3D-QSAR Study of Novel Chalcone Derivatives Containing Malonate and Pyridine Moieties

Synthesis and Antiviral Activity of Novel Pyrazole Amides Containing Α‐aminophosphonate Moiety

Novel Alpha, Beta-Unsaturated Amide Derivatives Bearing Alpha-Amino Phosphonate Moiety As Potential Antiviral Agents

Synthesis and Antiviral Activity of (E)-3-(4- or 6-Methylbenzo[d]thiazol-2-yl-amino)-2-cyano-3-(methylthio)acrylate Derivatives

Synthesis and Antiviral Activity of 5‑(4‑Chlorophenyl)-1,3,4-thiadiazole Sulfonamides